Met Life Investment Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 126,949 shares of BCRX stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
126,949
Previous 119,750 6.01%
Holding current value
$1.11 Million
Previous $910,000 4.84%
% of portfolio
0.01%
Previous 0.01%

Shares

43 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$7.03 - $8.43 $50,608 - $60,687
7,199 Added 6.01%
126,949 $954,000
Q2 2024

Aug 13, 2024
BUY
$4.13 - $6.79 $127,121 - $208,996
30,780 Added 34.6%
119,750 $740,000
Q1 2024

May 14, 2024
BUY
$4.89 - $7.65 $435,063 - $680,620
88,970 New
88,970 $451,000
Q2 2023

Apr 29, 2024
BUY
$6.96 - $8.81 $677,632 - $857,750
97,361 New
97,361 $685,000
Q1 2023

May 09, 2024
BUY
$7.94 - $11.84 $773,046 - $1.15 Million
97,361 New
97,361 $812 Million
Q1 2022

May 10, 2024
BUY
$11.56 - $19.76 $1.13 Million - $1.92 Million
97,361 New
97,361 $1.58 Million
Q1 2022

Mar 22, 2023
BUY
$11.56 - $19.76 $408,611 - $698,456
35,347 Added 57.0%
97,361 $1.58 Million
Q1 2022

May 12, 2022
BUY
$11.56 - $19.76 $408,611 - $698,456
35,347 Added 57.0%
97,361 $1.58 Million
Q4 2021

Jun 21, 2023
SELL
$11.18 - $15.46 $395,179 - $546,464
-35,347 Reduced 36.31%
62,014 $858,000
Q3 2021

May 17, 2024
SELL
$14.21 - $17.65 $87,618 - $108,829
-6,166 Reduced 9.04%
62,014 $891,000
Q3 2021

Jun 21, 2023
SELL
$14.21 - $17.65 $502,280 - $623,874
-35,347 Reduced 36.31%
62,014 $891,000
Q3 2021

Mar 22, 2023
SELL
$14.21 - $17.65 $87,618 - $108,829
-6,166 Reduced 9.04%
62,014 $891,000
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $87,618 - $108,829
-6,166 Reduced 9.04%
62,014 $891,000
Q2 2021

Jun 21, 2023
SELL
$9.5 - $17.24 $277,219 - $503,080
-29,181 Reduced 29.97%
68,180 $1.08 Million
Q1 2021

May 17, 2024
SELL
$7.37 - $13.61 $153,222 - $282,951
-20,790 Reduced 23.37%
68,180 $693,000
Q1 2021

Jun 26, 2023
SELL
$7.37 - $13.61 $215,063 - $397,153
-29,181 Reduced 29.97%
68,180 $693 Million
Q1 2021

Mar 22, 2023
SELL
$7.37 - $13.61 $34,417 - $63,558
-4,670 Reduced 6.41%
68,180 $693,000
Q1 2021

May 14, 2021
SELL
$7.37 - $13.61 $34,417 - $63,558
-4,670 Reduced 6.41%
68,180 $693,000
Q4 2020

May 24, 2024
BUY
$3.37 - $8.61 $9,331 - $23,841
2,769 Added 3.95%
72,850 $542,000
Q4 2020

Jun 22, 2023
SELL
$3.37 - $8.61 $82,602 - $211,039
-24,511 Reduced 25.18%
72,850 $542,000
Q4 2020

Mar 22, 2023
BUY
$3.37 - $8.61 $9,331 - $23,841
2,769 Added 3.95%
72,850 $542,000
Q4 2020

Feb 16, 2021
BUY
$3.37 - $8.61 $9,331 - $23,841
2,769 Added 3.95%
72,850 $543,000
Q3 2020

Jun 26, 2023
SELL
$3.43 - $5.53 $93,570 - $150,858
-27,280 Reduced 28.02%
70,081 $241,000
Q2 2020

May 24, 2024
SELL
$1.9 - $5.61 $35,889 - $105,967
-18,889 Reduced 21.23%
70,081 $334 Million
Q2 2020

Jun 26, 2023
SELL
$1.9 - $5.61 $51,832 - $153,040
-27,280 Reduced 28.02%
70,081 $333,000
Q2 2020

Mar 22, 2023
BUY
$1.9 - $5.61 $58,884 - $173,865
30,992 Added 79.29%
70,081 $333,000
Q2 2020

Aug 14, 2020
BUY
$1.9 - $5.61 $58,884 - $173,865
30,992 Added 79.29%
70,081 $334,000
Q1 2020

Jul 12, 2023
SELL
$1.6 - $4.11 $93,235 - $239,497
-58,272 Reduced 59.85%
39,089 $78,000
Q1 2020

Mar 22, 2023
SELL
$1.6 - $4.11 $50,176 - $128,889
-31,360 Reduced 44.51%
39,089 $78,000
Q1 2020

May 15, 2020
SELL
$1.6 - $4.11 $50,176 - $128,889
-31,360 Reduced 44.51%
39,089 $78,000
Q4 2019

Jul 12, 2023
SELL
$1.59 - $3.45 $42,790 - $92,846
-26,912 Reduced 27.64%
70,449 $243,000
Q4 2019

Mar 22, 2023
BUY
$1.59 - $3.45 $31,578 - $68,520
19,861 Added 39.26%
70,449 $243,000
Q4 2019

Feb 14, 2020
BUY
$1.59 - $3.45 $31,578 - $68,520
19,861 Added 39.26%
70,449 $243,000
Q3 2019

Jul 12, 2023
SELL
$2.5 - $3.73 $116,932 - $174,463
-46,773 Reduced 48.04%
50,588 $145,000
Q2 2019

Jul 12, 2023
SELL
$2.91 - $9.15 $136,109 - $427,972
-46,773 Reduced 48.04%
50,588 $191,000
Q1 2019

Jul 13, 2023
SELL
$7.38 - $9.72 $345,184 - $454,633
-46,773 Reduced 48.04%
50,588 $411,000
Q4 2018

Jul 13, 2023
SELL
$6.51 - $9.6 $304,492 - $449,020
-46,773 Reduced 48.04%
50,588 $408,000
Q4 2018

Mar 22, 2023
SELL
$6.51 - $9.6 $186,303 - $274,732
-28,618 Reduced 36.13%
50,588 $408,000
Q4 2018

Feb 14, 2019
SELL
$6.51 - $9.6 $186,303 - $274,732
-28,618 Reduced 36.13%
50,588 $408,000
Q3 2018

Jul 13, 2023
SELL
$5.52 - $7.99 $258,186 - $373,716
-46,773 Reduced 48.04%
50,588 $385,000
Q3 2018

Mar 22, 2023
SELL
$5.52 - $7.99 $100,215 - $145,058
-18,155 Reduced 18.65%
79,206 $604,000
Q3 2018

Nov 14, 2018
BUY
$5.52 - $7.99 $200,513 - $290,236
36,325 Added 84.71%
79,206 $604,000
Q4 2017

Feb 15, 2018
BUY
$4.16 - $5.33 $178,384 - $228,555
42,881
42,881 $211,000

Others Institutions Holding BCRX

# of Institutions
284
Shares Held
173M
Call Options Held
612K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.63B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email